-
-
-
-
D610013-25mgdual BRD4/PLK1 inhibitor 23.
-
D610013-5mgdual BRD4/PLK1 inhibitor 23.
-
D610014-25mgdual sEH/FAAH inhibitor 11.
-
D610014-5mgdual sEH/FAAH inhibitor 11.
-
D413851-100mgInformationDubermatinib(TP-0903) TP-0903 is a potent and selective AXL Inhibitor with IC50 of 27 nM. TP-0903 is highly effective in inducing apoptosis .TargetsAxl (Cell-free assay) 27 nMIn vitroIn pancreatic cancer cells (PSN-1), TP-0903 shows
-
D413851-10mgInformationDubermatinib(TP-0903) TP-0903 is a potent and selective AXL Inhibitor with IC50 of 27 nM. TP-0903 is highly effective in inducing apoptosis .TargetsAxl (Cell-free assay) 27 nMIn vitroIn pancreatic cancer cells (PSN-1), TP-0903 shows
-
D413851-25mgInformationDubermatinib(TP-0903) TP-0903 is a potent and selective AXL Inhibitor with IC50 of 27 nM. TP-0903 is highly effective in inducing apoptosis .TargetsAxl (Cell-free assay) 27 nMIn vitroIn pancreatic cancer cells (PSN-1), TP-0903 shows
-
D413851-50mgInformationDubermatinib(TP-0903) TP-0903 is a potent and selective AXL Inhibitor with IC50 of 27 nM. TP-0903 is highly effective in inducing apoptosis .TargetsAxl (Cell-free assay) 27 nMIn vitroIn pancreatic cancer cells (PSN-1), TP-0903 shows
-
D413851-5mgInformationDubermatinib(TP-0903) TP-0903 is a potent and selective AXL Inhibitor with IC50 of 27 nM. TP-0903 is highly effective in inducing apoptosis .TargetsAxl (Cell-free assay) 27 nMIn vitroIn pancreatic cancer cells (PSN-1), TP-0903 shows